NYSE American - Nasdaq Real Time Price USD

NovaBay Pharmaceuticals, Inc. (NBY)

0.0823 -0.0017 (-2.02%)
As of 12:36 PM EDT. Market Open.

Earnings Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 2222
Avg. Estimate -0.15-0.09-0.270.02
Low Estimate -0.25-0.14-0.41-0.02
High Estimate -0.05-0.04-0.130.07
Year Ago EPS -0.85-1.27-3.96-0.27

Revenue Estimate

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
No. of Analysts 2222
Avg. Estimate 3.28M3.58M14.8M19.29M
Low Estimate 3M3M13.5M17M
High Estimate 3.56M4.15M16.1M21.57M
Year Ago Sales 3.2M--14.73M14.8M
Sales Growth (year/est) 2.50%--0.50%30.30%

Earnings History

CURRENCY IN USD 3/31/2023 6/30/2023 9/30/2023 12/31/2023
EPS Est. -0.91-0.55-0.4-0.3
EPS Actual -0.85-1.27-0.37-1.33
Difference 0.06-0.720.03-1.03
Surprise % 6.60%-130.90%7.50%-343.30%

EPS Trend

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Current Estimate -0.15-0.09-0.270.02
7 Days Ago -0.25-0.14-0.410.07
30 Days Ago -0.2-0.2-0.730.01
60 Days Ago -0.2-0.2-0.730.01
90 Days Ago -0.22-0.18-0.640.01

EPS Revisions

CURRENCY IN USD Current Qtr. (Mar 2024)Next Qtr. (Jun 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days 111--
Up Last 30 Days 111--
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD NBYIndustrySectorS&P 500
Current Qtr. 82.40%----0.80%
Next Qtr. 92.90%----9.60%
Current Year 93.20%----4.50%
Next Year 107.40%----13.30%
Next 5 Years (per annum) ------11.09%
Past 5 Years (per annum) --------

Research Analysis

Analyst Price Targets

2.00
2.60 Average
0.0823 Current
3.20 High

Fair Value

Overvalued
% Return
0.0823 Current
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings

Consensus EPS
 

Upgrades & Downgrades

Maintains Ladenburg Thalmann: Buy to Buy 8/11/2023

Related Tickers